Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	+0,58%	+2,06%	+3,90%	+10,40%	50,73 mld.
REVOLUTION MEDICINES, INC.	-2,22%	-1,25%	+391,53%	+591,38%	39,73 mld.
IQVIA HOLDINGS INC.	-0,54%	+0,39%	+27,67%	-3,89%	34,69 mld.
BEONE MEDICINES AG	-1,36%	+0,35%	+19,34%	+58,83%	33,21 mld.
CELLTRION, INC.	+1,21%	-4,58%	+3,00%	+37,03%	26,76 mld.
ASCENDIS PHARMA A/S	-1,81%	-1,48%	-	-	16,8 mld.
MEDPACE HOLDINGS, INC.	+0,51%	-3,47%	+66,38%	+125,61%	15,37 mld.
EUROFINS SCIENTIFIC SE	+0,23%	-0,58%	+13,80%	+19,56%	13,78 mld.
ICON PUBLIC LIMITED COMPANY	-0,62%	-3,09%	+11,43%	-29,93%	12,85 mld.
Gemiddelde	-0,40%	-0,83%	+67,13%	+101,12%	27,1 mld.
Gewogen gemiddelde per kap.	-0,48%	-0,23%	+82,75%	+126,14%